arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Health Catalyst, Inc.

HCAT

$1.51 ▼ -0.09 (-5.63%) at close

10 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Health Catalyst, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $105.5M

Dividend Yield —

Revenue Growth 1.5% ↘

Op. Margin -51.7% ↘

ROIC -40.5% ↘

FCF / Share $-0.00 ↘

Trailing P/E —

Price / Book 0.4x

FCF Yield —

Debt / Equity 0.62

info Valuation on last close. End-of-day price, Nov 5, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$311.14M

↑ +1.5% —

Net Income Profit after all expenses

$-177.97M

↓ -156.1% —

Operating Margin Operating profit as % of sales

-51.7%

↓ -127.1% 5th

FCF / Share Free cash flow per share

$-0.00

↓ -101.6% —

Long-Term Debt Long-term obligations

$153.25M

↓ -59.9% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	1.5% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-88%)	3.6% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-70%)	7.1% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-41%)	14.2% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+18%)	28.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+134%)	21.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+82%)	37.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+214%)	54.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+350%)	—	—
EPS Growth YoY (%)	-121.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	45.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	18.4% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	20.7% Good Good Year-over-year change in earnings per share Optimal: > 10%	-11.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-156.1% Weak ↓ Weak Declining Year-over-year change in net income	41.2% Excellent ↑ Excellent Improving Year-over-year change in net income	14.0% Fair ↑ Fair Improving Year-over-year change in net income	10.3% Fair ↑ Fair Improving Year-over-year change in net income	-33.2% Weak ↑ Weak Improving Year-over-year change in net income	-91.4% Weak ↓ Weak Declining Year-over-year change in net income	3.0% Caution Caution Year-over-year change in net income	-31.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	N/M	12.7% Fair ↑ Fair Improving Year-over-year change in free cash flow	1.4% Caution Caution Year-over-year change in free cash flow	17.6% Good Good Year-over-year change in free cash flow	—	—	—	—	—
Revenue CAGR 3Y (%)	4.0% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	8.2% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	16.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	21.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	29.0% Excellent Excellent Compound annual revenue growth over 3 years	37.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	10.5% Good ↓ Good Declining Compound annual revenue growth over 5 years	14.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	21.3% Excellent Excellent Compound annual revenue growth over 5 years	30.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	-51.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-358%)	-22.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-214%)	-42.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-314%)	-50.7% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-353%)	-59.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-397%)	-50.9% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-355%)	-35.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-277%)	-53.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-367%)	-62.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-412%)	—
Effective Tax Rate (%) (%)	-0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-57.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-481%)	-22.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-251%)	-39.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-366%)	-49.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-432%)	-63.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-522%)	-60.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-506%)	-38.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-359%)	-55.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-467%)	-64.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-529%)	—
FCF Margin (%) (%)	-0.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	4.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-11.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-13.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-13.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-18.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-22.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-37.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-53.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.19x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.29x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.27x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.22x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.29x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	-40.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-16.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	13.3% Good Good Return earned on debt + equity capital invested Optimal: > 10%	13.9% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-32.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-18.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-54.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-72.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-491%)	-19.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-203%)	-32.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-274%)	-32.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-275%)	-29.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-259%)	-41.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-325%)	-30.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-262%)	16.5% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-11%)	18.1% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Debt to Equity (x)	0.62x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+39%)	1.05x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+133%)	0.62x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+38%)	0.53x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+18%)	0.35x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-23%)	0.61x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+36%)	0.24x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-47%)	-0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-111%)	—	—
Interest Coverage (x)	-7.33x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.90x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-22.07x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-24.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-22.59x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-19.31x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.87x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-15.26x Weak Weak Operating income divided by interest expense Optimal: > 5x	-44.13x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$102.44M	$132.72M	$121.76M	$110.21M	$-12.29M	$77.04M	$30.17M	$-9.62M	—	—
Debt / EBITDA (x)	-1.05x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-6.71x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.00x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.76x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.31x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.81x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.93x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.33x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue per Share (USD)	$4.45	$5.09	$5.25	$5.14	$5.09	$4.78	—	—	—	—
Basic EPS, GAAP (USD)	$-2.55	$-1.15	$-2.09	$-2.56	$-3.23	$-2.91	—	—	—	—
Free Cash Flow per Share (USD)	$-0.00	$0.22	$-0.61	$-0.70	$-0.71	$-0.86	—	—	—	—
Book Value per Share (USD)	$3.41	$5.70	$6.29	$7.69	$9.92	$6.37	$5.47	—	—	—
Tangible Book Value per Share (USD)	$-0.57	$0.30	$1.76	$2.66	$4.70	$1.60	$4.67	—	—	—
Basic Weighted Avg Shares (shares)	69.90M	60.18M	56.42M	53.72M	47.49M	39.54M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$79.73M	$139.80M	$304.36M	$345.29M	$415.34M	$241.76M	$216.02M	$25.05M	—	—
LT Debt (USD)	$153.25M	$382.36M	$228.03M	$226.52M	$180.94M	$168.99M	$48.20M	$18.81M	—	—
Total Equity (USD)	$245.78M	$365.21M	$366.92M	$425.01M	$522.10M	$276.10M	$200.64M	$-374.77M	$-259.48M	$-206.41M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	$311.14M	$306.58M	$295.94M	$276.24M	$241.93M	$188.84M	$154.94M	$112.57M	$73.08M	—
Depreciation Expense (USD)	$15.00M	$12.80M	$12.60M	$11.10M	$5.50M	$2.90M	$2.90M	$2.30M	$1.40M	—
Net Income, GAAP (USD)	$-177.97M	$-69.50M	$-118.15M	$-137.40M	$-153.21M	$-115.02M	$-60.10M	$-61.98M	$-47.03M	—
Operating Cash Flow (USD)	$731.00K	$14.56M	$-33.08M	$-35.27M	$-23.12M	$-26.15M	$-32.18M	$-40.30M	$-36.83M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 10 years · 36 quarters

Health Catalyst, Inc.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HCAT with peers